GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,389.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,113.33m
  • Volume: 7,504,355
  • Market Cap: £57,134m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
2.89% below the market average2.89% below the market average2.89% below the market average2.89% below the market average2.89% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
1yr Revenue Growth
4.52% below the market average4.52% below the market average4.52% below the market average4.52% below the market average4.52% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
18.53% above the market average18.53% above the market average18.53% above the market average18.53% above the market average18.53% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
6.09% above the market average6.09% above the market average6.09% above the market average6.09% above the market average6.09% above the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
7.74% below the market average7.74% below the market average7.74% below the market average7.74% below the market average7.74% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Price Book Ratio
78.11% below the market average78.11% below the market average78.11% below the market average78.11% below the market average78.11% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
38.19% below the market average38.19% below the market average38.19% below the market average38.19% below the market average38.19% below the market average
29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average
Price Chg 3m
50.19% above the market average50.19% above the market average50.19% above the market average50.19% above the market average50.19% above the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
23.65% below the market average23.65% below the market average23.65% below the market average23.65% below the market average23.65% below the market average
42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average
Momentum 20
90.94% below the market average90.94% below the market average90.94% below the market average90.94% below the market average90.94% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
18.11% above the market average18.11% above the market average18.11% above the market average18.11% above the market average18.11% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
ROCE
70.54% above the market average70.54% above the market average70.54% above the market average70.54% above the market average70.54% above the market average
Sector averageSector averageSector averageSector averageSector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.86% above the market average91.86% above the market average91.86% above the market average91.86% above the market average91.86% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Forecast EPS
79.83% above the market average79.83% above the market average79.83% above the market average79.83% above the market average79.83% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
Operating Profit Loss
98.09% above the market average98.09% above the market average98.09% above the market average98.09% above the market average98.09% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average
Cash
96.83% above the market average96.83% above the market average96.83% above the market average96.83% above the market average96.83% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
72.86% above the market average72.86% above the market average72.86% above the market average72.86% above the market average72.86% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Buys 1y
99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
95.49% below the market average95.49% below the market average95.49% below the market average95.49% below the market average95.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
72.64% above the market average72.64% above the market average72.64% above the market average72.64% above the market average72.64% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,389.00p
Change Today -5.00p
% Change -0.36 %
52 Week High 1,812.50
52 Week Low 1,264.00
Volume 7,504,355
Shares Issued 4,113.33m
Market Cap £57,134m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.15% below the market average39.15% below the market average39.15% below the market average39.15% below the market average39.15% below the market average
44.68% above the sector average44.68% above the sector average44.68% above the sector average44.68% above the sector average44.68% above the sector average
Price Trend
12.83% below the market average12.83% below the market average12.83% below the market average12.83% below the market average12.83% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
71.62% above the market average71.62% above the market average71.62% above the market average71.62% above the market average71.62% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
44.04% below the market average44.04% below the market average44.04% below the market average44.04% below the market average44.04% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 25-Apr-2025

Time Volume / Share Price
16:25 0 @ 1,390.00p
16:38 2,580 @ 1,389.00p
16:38 2,580 @ 1,389.00p
15:43 67 @ 1,388.00p
16:36 20 @ 1,389.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page